Search for Stocks /

Vijaya Diagnostics Q1 FY26: ₹188 Cr Revenue, 22% Profit Surge & a Merger Hangover That Tastes Sweet

Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.

1. At a Glance

Vijaya Diagnostics flexed with Q1 FY26 revenue at ₹188 Cr (+20% YoY) and PAT at ₹39 Cr (+22% YoY). High P/E? Yes, 78x. But the market still loves this South Indian diagnostic kingpin.


2. Introduction

Imagine a health check-up package that doesn’t drain your wallet but still gives you a clean bill of health. Vijaya is that – steady, profitable, and slightly overpriced, like your favourite organic avocado toast.


3. Business Model – WTF Do They Even Do?

  • Core: Diagnostic tests, radiology, nuclear medicine, health check-ups.
  • Scale: 81 centers, 11 labs, 13 cities.
  • Special Sauce: First in South India to bring PET-CT scans; now expanding like a diagnostic octopus.

4. Financials Overview

  • Q1 FY26 Revenue: ₹188 Cr
  • PAT: ₹39 Cr
  • OPM: 39% (lab coats printing
Read Full 16 Point breakdown. Continue reading →
EduInvesting runs entirely on reader support — ₹360 a year keeps the lights on.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →